Mark Fruendt, D.O.
NPI 1306164223 · Family Medicine Physician · Huntsville, AL
Enrolled with Medicare as Practitioner - Family Practice · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1306164223
- Entity type
- Individual
- Primary specialty
- Family Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- D.O.
- Sex
- Male
- Sole proprietor
- No
- License
- L.3347R (AL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
16 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
292 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 141 | $106 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 68 | $78 |
| Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804 | 23 | $13 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 19 | $13 |
| Detection Test By Immunoassay With Direct Visual Observation for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)87811 | 14 | $29 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 40 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Amlodipine Besylate | 79 | 30 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 78 | 26 |
| Furosemide | 50 | 26 |
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 46 | 15 |
| Doxycycline Monohydrate | 41 | 36 |
| Levothyroxine Sodium | 38 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$101 across 6 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2010-05-17
- Last updated
- 2024-08-15
- Certified
- 2024-08-15
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.